Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 160

Results For "program"

1759 News Found

Network18 Group and Novartis India launch ‘Netra Suraksha’ to raise awareness around diabetic eye diseases
Events | November 27, 2021

Network18 Group and Novartis India launch ‘Netra Suraksha’ to raise awareness around diabetic eye diseases

The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly


Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron
Biotech | November 26, 2021

Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron

The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease


Baidu and Sanofi to collaborate for next-gen mRNA therapy and vaccines
Biotech | November 26, 2021

Baidu and Sanofi to collaborate for next-gen mRNA therapy and vaccines

This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs


Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
Biotech | November 26, 2021

Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline

Owkin builds best-in-class predictive biomedical AI models and robust data sets


Boehringer Ingelheim India enters Guinness World Records through its Stroke campaign
Healthcare | November 25, 2021

Boehringer Ingelheim India enters Guinness World Records through its Stroke campaign

The week-long campaign received a record 17.691 pledges


ADB approves US $ 1.5 bn for Covid-19 vaccines in India
News | November 25, 2021

ADB approves US $ 1.5 bn for Covid-19 vaccines in India

The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people


Arrowhead Pharmaceuticals enters agreement with GSK to develop NASH drug candidate
Biotech | November 24, 2021

Arrowhead Pharmaceuticals enters agreement with GSK to develop NASH drug candidate

Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales


Asian Development Bank to loan US $ 300 mn to improve India’s primary healthcare
Public Health | November 24, 2021

Asian Development Bank to loan US $ 300 mn to improve India’s primary healthcare

The programme will be implemented across 13 states and benefit 256 min


Serum Life Sciences invests US $ 10 million in GreenLight Biosciences
Biotech | November 24, 2021

Serum Life Sciences invests US $ 10 million in GreenLight Biosciences

GreenLight Biosciences is a Boston-based biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible


Vital Strategies India appoints L. M. Singh as MD, India and Global Head, Partnerships and Innovative Finance
People | November 24, 2021

Vital Strategies India appoints L. M. Singh as MD, India and Global Head, Partnerships and Innovative Finance

In his new role as Managing Director India and Global Head, Partnerships and Innovative Finance, Singh will oversee the financial, human, and operational functions of the India office